Chemotherapeutic drugs typically induce peripheral neuropathy, which is a major dose-limiting side effect of these drugs and is difficult to manage. In this study, we examined whether the traditional herbal formulation Kei-kyoh-zoh-soh-oh-shin-bu-toh (KSOT) could relieve the mechanical allodynia induced by chemotherapeutic drugs (oxaliplatin, paclitaxel, vincristine, and bortezomib) in mice. A single intraperitoneal injection of oxaliplatin, paclitaxel, vincristine, and bortezomib was used to induce mechanical allodynia, which peaked on days 10, 14, 14, and 12 after the injection, respectively. A single oral administration of KSOT did not inhibit mechanical allodynia after any of the treatments. However, prophylactic repetitive oral adminis...
Background. Treatment of chemotherapy-induced peripheral neuropathy (CIPN) remains a big challenge f...
Chemotherapy-induced peripheral neuropathy (CIPN) is a major drawback in the use of chemotherapeutic...
Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect caused by chemother...
Abstract Background Oxaliplati...
Oxaliplatin-induced peripheral neuropathy characterized especially as cold dysesthesia is a major do...
AbstractOxaliplatin-induced peripheral neuropathy characterized especially as cold dysesthesia is a ...
Although oxaliplatin is a well-known anti-cancer agent used for the treatment of colorectal cancer, ...
AbstractOxaliplatin causes peripheral neuropathy as a major dose-limiting side effect, and the contr...
Background. Peripheral neurotoxicity caused by oxaliplatin (OXA) chemotherapy is the main limitation...
Oxaliplatin, a chemotherapy drug, induces acute peripheral neuropathy characterized by cold allodyni...
Oxaliplatin, a chemotherapy drug, induces acute peripheral neuropathy characterized by cold allodyni...
http://creativecommons.org/licenses/by/3.0/Peripheral neurotoxicity is the major limiting factor for...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
AbstractOxaliplatin causes peripheral neuropathy as a major dose-limiting side effect, and the contr...
Pacliatxel is a taxol-based chemotherapeutic drug that is widely used to treat cancer. However, it c...
Background. Treatment of chemotherapy-induced peripheral neuropathy (CIPN) remains a big challenge f...
Chemotherapy-induced peripheral neuropathy (CIPN) is a major drawback in the use of chemotherapeutic...
Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect caused by chemother...
Abstract Background Oxaliplati...
Oxaliplatin-induced peripheral neuropathy characterized especially as cold dysesthesia is a major do...
AbstractOxaliplatin-induced peripheral neuropathy characterized especially as cold dysesthesia is a ...
Although oxaliplatin is a well-known anti-cancer agent used for the treatment of colorectal cancer, ...
AbstractOxaliplatin causes peripheral neuropathy as a major dose-limiting side effect, and the contr...
Background. Peripheral neurotoxicity caused by oxaliplatin (OXA) chemotherapy is the main limitation...
Oxaliplatin, a chemotherapy drug, induces acute peripheral neuropathy characterized by cold allodyni...
Oxaliplatin, a chemotherapy drug, induces acute peripheral neuropathy characterized by cold allodyni...
http://creativecommons.org/licenses/by/3.0/Peripheral neurotoxicity is the major limiting factor for...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
AbstractOxaliplatin causes peripheral neuropathy as a major dose-limiting side effect, and the contr...
Pacliatxel is a taxol-based chemotherapeutic drug that is widely used to treat cancer. However, it c...
Background. Treatment of chemotherapy-induced peripheral neuropathy (CIPN) remains a big challenge f...
Chemotherapy-induced peripheral neuropathy (CIPN) is a major drawback in the use of chemotherapeutic...
Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect caused by chemother...